Decreased suburethral prostatic microvessel density in finasteride treated prostates: A possible mechanism for reduced bleeding in benign prostatic hyperplasia

Journal of Urology

Volumn 167, Issue 4 I, 2002, Pages 1731-1733

  Hochberg, David A ^a,b   Basillote, Jay B ^a   Armenakas, Noel A ^a   Vasovic, Liliana ^a   Shevchuk, Maria ^a   Pareek, Gyan ^a   Fracchia, John A ^a  

^a LENOX HILL HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

Blood vessels; Finasteride; Hematuria; Prostate; Prostatic hyperplasia

Indexed keywords

FINASTERIDE;

ADULT; AGED; ARTICLE; BLADDER SPHINCTER; BLEEDING; CLINICAL ARTICLE; DATA ANALYSIS; DRUG EFFECT; HEMATURIA; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; STROMA CELL;

EID: 0036129719     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(05)65188-9     Document Type: Article

References (16)

1. Effects of finasteride on hematuria associated with benign prostatic hyperplasia: Long-term follow-up
2. Microvessel density in prostatic hyperplasia
3. CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy
4. Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients
5. A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride
6. Treatment of prostatic bleeding: Suppression of angiogenesis by androgen deprivation
7. The effects of finasteride on hematuria associated with benign prostatic hyperplasia: A preliminary report
8. Androgens induce the expression of vascular endothelial growth factors in human fetal prostatic fibroblasts
9. Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats
10. The effects of androgen deprivation on the prostate gland: Cell death mediated by vascular regression
11. Endothelial cell proliferation activity in benign prostatic hyperplasia and prostate cancer: An in vitro model for assessment
12. Comparison of microscopic vascularity in benign and malignant prostate tissue
13. Angiogenesis and breast cancer
14. Microvascularity in benign prostatic hyperplasia
15. Finasteride inhibits angiogenesis and expression of VEGF in human BPH
16. Effect of finasteride on microvessel density (MVD) in patients with recurrent hematuria related to prostatic hypertrophy (BPH)